Ketorolac Tromethamine
Average across 8 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| ONESOURCE SPECIALTY PHARMA LIMITED | unknown | 6 | SUPPLYING |
| Hikma Pharmaceuticals USA Inc. | unknown | 3 | SUPPLYING |
| SUN PHARMACEUTICAL INDUSTRIES, INC. | unknown | 3 | SUPPLYING |
| A-S Medication Solutions | unknown | 3 | SUPPLYING |
| SOLA Pharmaceuticals, LLC | unknown | 3 | SUPPLYING |
| Alembic Pharmaceuticals Limited | unknown | 3 | SUPPLYING |
| Medical Purchasing Solutions, LLC | unknown | 2 | SUPPLYING |
| Sportpharm LLC | unknown | 1 | SUPPLYING |
| Nephron Pharmaceuticals Corporation | unknown | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
cGMP Deviations: deviations leading to potential cross-contamination. — Recalling firm: Nephron Sc Inc — USA Nationwide
Presence of Particulate Matter: particles identified as polydimethylsiloxane (PDMS) — Recalling firm: Hikma Pharmaceuticals USA Inc. — Nationwide within the United States
Presence of Particulate Matter: particles identified as polydimethylsiloxane (PDMS) — Recalling firm: Hikma Pharmaceuticals USA Inc. — Nationwide within the United States
Ketorolac Tromethamine Injection — reported in shortage by Hikma Pharmaceuticals USA, Inc.. Therapeutic category: Analgesia/Addiction.
Ketorolac Tromethamine Injection — reported in shortage by Alembic Pharmaceuticals. Therapeutic category: Analgesia/Addiction.
Pill